Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
   H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
   H02 CORTICOSTEROIDS FOR SYSTEMIC USE
     H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
       H02AA Mineralocorticoids
       H02AB Glucocorticoids
         H02AB01 Betamethasone [DG:DG00095]
         H02AB02 Dexamethasone [DG:DG00011]
         H02AB03 Fluocortolone [DG:DG00295]
         H02AB04 Methylprednisolone [DG:DG00410]
         H02AB05 Paramethasone [DG:DG00508]
         H02AB06 Prednisolone [DG:DG00093]
         H02AB07 Prednisone [DG:DG00094]
         H02AB08 Triamcinolone [DG:DG00010]
         H02AB09 Hydrocortisone [DG:DG00012]
         H02AB10 Cortisone [DG:DG00509]
           D07749  Cortisone (INN)
           D00973  Cortisone acetate (JP17/USP) <JP/US>
         H02AB11 Prednylidene
         H02AB12 Rimexolone
         H02AB13 Deflazacort
         H02AB14 Cloprednol
         H02AB15 Meprednisone
         H02AB17 Cortivazol
     H02B CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS
     H02C ANTIADRENAL PREPARATIONS
   H03 THYROID THERAPY
   H04 PANCREATIC HORMONES
   H05 CALCIUM HOMEOSTASIS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
   S01 OPHTHALMOLOGICALS
     S01A ANTIINFECTIVES
     S01B ANTIINFLAMMATORY AGENTS
       S01BA Corticosteroids, plain
         S01BA01 Dexamethasone [DG:DG00011]
         S01BA02 Hydrocortisone [DG:DG00012]
         S01BA03 Cortisone [DG:DG00509]
           D07749  Cortisone (INN)
           D00973  Cortisone acetate (JP17/USP) <JP/US>
         S01BA04 Prednisolone [DG:DG00093]
         S01BA05 Triamcinolone [DG:DG00010]
         S01BA06 Betamethasone [DG:DG00095]
         S01BA07 Fluorometholone [DG:DG00294]
         S01BA08 Medrysone
         S01BA09 Clobetasone [DG:DG00411]
         S01BA10 Alclometasone [DG:DG00415]
         S01BA11 Desonide
         S01BA12 Formocortal
         S01BA13 Rimexolone
         S01BA14 Loteprednol [DG:DG01127]
         S01BA15 Fluocinolone acetonide
       S01BB Corticosteroids and mydriatics in combination
       S01BC Antiinflammatory agents, non-steroids
     S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
     S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
     S01F MYDRIATICS AND CYCLOPLEGICS
     S01G DECONGESTANTS AND ANTIALLERGICS
     S01H LOCAL ANESTHETICS
     S01J DIAGNOSTIC AGENTS
     S01K SURGICAL AIDS
     S01L OCULAR VASCULAR DISORDER AGENTS
     S01X OTHER OPHTHALMOLOGICALS
   S02 OTOLOGICALS
   S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: November 2, 2020
According to WHO's ATC 2020

» Japanese version